| Complex immune dysregulation in COVID-19 patients with severe respiratory failure EJ Giamarellos-Bourboulis, MG Netea, N Rovina, K Akinosoglou, ... Cell host & microbe 27 (6), 992-1000. e3, 2020 | 2126 | 2020 |
| DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Clinical infectious diseases 58 (8), 1072-1083, 2014 | 1054 | 2014 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 439 | 2021 |
| Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison IE Galani, N Rovina, V Lampropoulou, V Triantafyllia, M Manioudaki, ... Nature immunology 22 (1), 32-40, 2021 | 435 | 2021 |
| Respiratory failure C Roussos, A Koutsoukou European Respiratory Journal 22 (47 suppl), 3s-14s, 2003 | 432 | 2003 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 329 | 2021 |
| Inflammation and immune response in COPD: where do we stand? N Rovina, A Koutsoukou, NG Koulouris Mediators of inflammation 2013, 2013 | 287 | 2013 |
| Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients AC Aschenbrenner, M Mouktaroudi, B Krämer, M Oestreich, N Antonakos, ... Genome medicine 13, 1-25, 2021 | 230 | 2021 |
| Validation of the new Sepsis-3 definitions: proposal for improvement in early risk identification EJ Giamarellos-Bourboulis, T Tsaganos, I Tsangaris, M Lada, C Routsi, ... Clinical Microbiology and Infection 23 (2), 104-109, 2017 | 187 | 2017 |
| Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An … MH Abdul-Aziz, J Lipman, M Akova, M Bassetti, JJ De Waele, ... Journal of Antimicrobial Chemotherapy 71 (1), 196-207, 2016 | 167 | 2016 |
| Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease I Vogiatzis, O Georgiadou, S Golemati, A Aliverti, E Kosmas, E Kastanakis, ... Thorax 60 (9), 723-729, 2005 | 158 | 2005 |
| Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen N Spanakis, S Tsiodras, BL Haagmans, VS Raj, K Pontikis, A Koutsoukou, ... International journal of antimicrobial agents 44 (6), 528-532, 2014 | 139 | 2014 |
| Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis NG Koulouris, S Retsou, E Kosmas, K Dimakou, K Malagari, ... European Respiratory Journal 21 (5), 743-748, 2003 | 131 | 2003 |
| Colistin population pharmacokinetics after application of a loading dose of 9 MU colistin methanesulfonate in critically ill patients I Karaiskos, LE Friberg, K Pontikis, K Ioannidis, V Tsagkari, L Galani, ... Antimicrobial agents and chemotherapy 59 (12), 7240-7248, 2015 | 130 | 2015 |
| Expiratory flow limitation and intrinsic positive end-expiratory pressure at zero positive end-expiratory pressure in patients with adult respiratory distress syndrome A KOUTSOUKOU, A ARMAGANIDIS, C STAVRAKAKI-KALLERGI, ... American Journal of Respiratory and Critical Care Medicine 161 (5), 1590-1596, 2000 | 130 | 2000 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| Effects of positive end-expiratory pressure on gas exchange and expiratory flow limitation in adult respiratory distress syndrome A Koutsoukou, B Bekos, C Sotiropoulou, NG Koulouris, C Roussos, ... Critical care medicine 30 (9), 1941-1949, 2002 | 109 | 2002 |
| Critically ill cancer patient in intensive care unit: issues that arise E Kostakou, N Rovina, M Kyriakopoulou, NG Koulouris, A Koutsoukou Journal of critical care 29 (5), 817-822, 2014 | 104 | 2014 |
| Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa SD Mentzelopoulos, M Pratikaki, E Platsouka, H Kraniotaki, D Zervakis, ... Intensive care medicine 33, 1524-1532, 2007 | 96 | 2007 |
| Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma EN Kosmas, J Milic-Emili, A Polychronaki, I Dimitroulis, S Retsou, M Gaga, ... European Respiratory Journal 24 (3), 378-384, 2004 | 89 | 2004 |
